FC
MDCO

Fayerweather Charles’s Medicines Co MDCO Stock Holding History

Fayerweather Charles’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-4,750
Closed -$237K – 55
2019
Q3 		$237K Buy
+4,750
New +$189K 0.42% 50
2017
Q3 		– Sell
-8,750
Closed -$333K – 64
2017
Q2 		$333K Hold
8,750
– – 0.45% 52
2017
Q1 		$428K Buy
+8,750
New +$399K 0.61% 47

Other funds holding MDCO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Fayerweather Charles's MDCO Position: Q4 2019 in Review

Fayerweather Charles sold out of Medicines Co (MDCO) in Q4 2019, closing a stake of 4,750 shares — an estimated $237K sold.

Fayerweather Charles first reported a position in MDCO in Q1 2017 and held it in 3 quarters. The position peaked at $428K in Q1 2017. 284 funds tracked by Wall St. Rank hold MDCO as of Q4 2019.

  • Fayerweather Charles reported no remaining Medicines Co position as of Q4 2019 after selling out during the quarter.
  • Fayerweather Charles sold 4,750 Medicines Co shares in Q4 2019, an estimated $237K.
  • Fayerweather Charles first reported a position in Medicines Co in Q1 2017 and held it in 3 quarters.
  • Fayerweather Charles's Medicines Co position peaked at $428K in Q1 2017.
  • 284 funds tracked by Wall St. Rank held Medicines Co as of Q4 2019.

Based on Fayerweather Charles's 13F filing for Q4 2019, filed 15 Jan 2020.